|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61P 35/00 | (2006.01) |
| C07D 401/14 | (2006.01) | ||
| C07D 403/04 | (2006.01) | ||
| C07D 403/14 | (2006.01) | ||
| C07D 405/14 | (2006.01) | ||
| C07D 413/14 | (2006.01) | ||
| C07D 417/14 | (2006.01) | ||
| C07D 471/04 | (2006.01) | ||
| C07D 487/04 | (2006.01) | ||
| A61K 31/416 | (2006.01) | ||
| A61K 31/4439 | (2006.01) | ||
| A61K 31/506 | (2006.01) | ||
| A61K 31/437 | (2006.01) | ||
| A61K 31/502 | (2006.01) | ||
| A61K 31/517 | (2006.01) | ||
| A61K 31/538 | (2006.01) | ||
| A61K 31/425 | (2006.01) |
| (11) | Number of the document | 4076662 |
| (13) | Kind of document | T |
| (96) | European patent application number | 20829365.4 |
| Date of filing the European patent application | 2020-12-17 | |
| (97) | Date of publication of the European application | 2022-10-26 |
| (45) | Date of publication and mention of the grant of the patent | 2024-01-31 |
| (46) | Date of publication of the claims translation | 2024-05-10 |
| (86) | Number | PCT/IB2020/062144 |
| Date | 2020-12-17 |
| (87) | Number | WO 2021/124222 |
| Date | 2021-06-24 |
| (30) | Number | Date | Country code |
| 201962951400 P | 2019-12-20 | US | |
| PCT/CN2020/125425 | 2020-10-30 | WO |
| (72) |
COTESTA, Simona , CH
GERSPACHER, Marc , CH
LEBLANC, Catherine , CH
LIU, Bo , CN
LORTHIOIS, Edwige Liliane Jeanne , CH
MACHAUER, Rainer , CH
MAH, Robert , CH
MURA, Christophe , CH
RIGOLLIER, Pascal , CH
SCHNEIDER, Nadine , CH
STUTZ, Stefan , CH
VAUPEL, Andrea , CH
WARIN, Nicolas , CH
WILCKEN, Rainer , CH
|
| (73) |
Novartis AG ,
Lichtstrasse 35, 4056 Basel,
CH
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Pirazolilo dariniai, naudingi kaip priemonės nuo vėžio |
| PYRAZOLYL DERIVATIVES USEFUL AS ANTI-CANCER AGENTS |
| Payment date | Validity (years) | Amount | |
| 2025-04-22 | 5 | 172.50 EUR |
| 2025-12-17 |